Future Directions in DLBCL: Innovations in the Frontline and Relapsed Settings

(MedPage Today) — Ahead of the upcoming American Society of Hematology (ASH) annual meeting, Alex Niu, MD, of Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses the evolving therapeutic landscape for diffuse large B-cell…

Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/118786

Author :

Publish date : 2025-12-02 17:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Future Directions in DLBCL: Innovations in the Frontline and Relapsed Settings

Join the Lifeline Chorus and Help Fight AMR

Polypharmacy Is a Real Issue. Dismantling Public Health Won’t Fix It.

Related Posts

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Rising LATE Dementia Diagnoses; Wooden Neurons; Remyelination Trial Fails

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Rising LATE Dementia Diagnoses; Wooden Neurons; Remyelination Trial Fails

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

Categories

Archives